CASI Pharmaceuticals CASIF
OTC CASIF
$0.10 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

CASI Pharmaceuticals (CASIF) Work In Process (2025)

Updated

CASI Pharmaceuticals (CASIF) posted Work In Process of $504,000 for Q4 2025.

Analysis

CASI Pharmaceuticals (CASIF) Work In Process (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CASI Pharmaceuticals 2.06 Mn -18.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 504,000.00
API Access

CASI Pharmaceuticals Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=CASIF&period=max&api_key=YOUR_API_KEY